How to Buy Globus Medical Stock
Globus Medical Inc
Globus Medical is a medical device company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker GMED on the NYSE exchange.
Globus Medical stock last closed at $85.67, down 3.02% from the previous day, and has increased 41.07% in one year. It has overperformed other stocks in the Medical Devices industry by 1.41 percentage points. Globus Medical stock is currently +58.21% from its 52-week low of $54.15, and -15.51% from its 52-week high of $101.40.
There are currently 134.26M GMED shares outstanding. The market value of GMED is $11.50B. In the last 24 hours, 848,000 GMED shares were traded.
How to Buy Globus Medical Stock
Wondering how to invest in Globus Medical stock? Here's how.
- Choose where to buy Globus Medical stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Globus Medical stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your payment method and add your info.
- Research Globus Medical stock: The Globus Medical ticker symbol is GMED. Is Globus Medical stock a good investment? Should you buy shares of GMED? How do GMED's underlying business fundamentals look? Do top analysts think Globus Medical is a good buy? Why has GMED's stock price moved recently? (Hint: Our stock market research website can help you evaluate if GMED is a good stock to buy).
- Make your GMED trade: Decide if you will purchase GMED shares at the current market price or use a limit order to purchase GMED shares at a particular price.
- Keep an eye on your GMED position: Create a watchlist to get live updates on your new investment in Globus Medical shares.
Step 1: Choose where to buy Globus Medical stock
You need a brokerage account to access the NYSE market and buy GMED shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you can buy GMED today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've filled out your info on apps for stock market, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details depositing money into your new brokerage account.
Step 4: Research Globus Medical stock
Once you have decided on the best place to buy Globus Medical stock, it's critical to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Globus Medical stock at a glance
GMED Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on GMED's stock page.
How is GMED stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge GMED's fair value.
Using relative valuations methods:
- GMED may be undervalued based on its P/E ratio of 21.58x, relative to Medical Devices industry P/E ratio of 24.05x
- GMED could be undervalued based on its P/B ratio of 2.41x, relative to Medical Devices industry P/B ratio of 3.35x
- GMED may be overvalued based on its PEG ratio of 1.63x
You can access additional valuation analysis on GMED's stock here.
How do GMED Financials look?
Pros:
- There are more short-term assets than short-term liabilities on the GMED balance sheet.
- GMED profit margin has gone up from 13.6% to 17% in the past year.
- There are more short-term assets than long-term liabilities on the GMED balance sheet.
- GMED's operating cash flow of $910.39M allows it to safely service it's debt of $111.19M.
- GMED earnings of $642.84M is not sufficient to cover its interest payments.
- GMED has a low debt to equity ratio of 0.15.
Cons:
- Total GMED debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy Globus Medical stock
Out of 9 sell side analysts who give recommendations on GMED, the consensus analyst rating on Globus Medical is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest GMED Analyst Recommendations
Tom Stephan, a bottom 48% analyst from Stifel Nicolaus maintains GMED with a hold rating and lowers their GMED price target from $95.00 to $80.00, on Jul 8, 2026.
Matthew O'Brien, a bottom 5% analyst from Piper Sandler maintains GMED with a strong buy rating and lowers their GMED price target from $115.00 to $100.00, on Jun 15, 2026.
David Saxon, a top 19% analyst from Needham maintains GMED with a buy rating and raises their GMED price target from $114.00 to $117.00, on May 8, 2026.
Vik Chopra, a top 29% analyst from Wells Fargo maintains GMED with a strong buy rating and raises their GMED price target from $98.00 to $104.00, on Feb 26, 2026.
Wells Fargo's Vik Chopra raised their price target on Globus Medical (NYSE: GMED) by 6.1% from $98 to $104 on 2026/02/26. The analyst maintained their Strong Buy rating on the stock.
Globus Medical reported its Q4 and FY 2025 earnings.
With Nevro still in the early stages of improving its margins, Chopra said a viable road to EBITDA margins in the mid-30s is visible, given the company's 33.9% consolidated EBITDA.
Earnings Report
Globus Medical reported:
For Q4 2025:
- EPS of $1.28, which beat the Zacks Consensus Estimate of $1.06 and, by 52.1%, Q4 2024’s $0.84.
- Revenue of $826.42M, which beat the Zacks Consensus Estimate by 4.90% and, by 25.7%, Q4 2024’s $657.29M.
For FY 2025:
- EPS of $3.98, up 30.8% Y/Y.
- Revenue of $2.94B, up 16.7% Y/Y.
For FY 2026, management guided:
- EPS of $4.40 to $4.50.
- Revenue of $3.18B to $3.22B.
President & CEO Keith Pfeil commented: “Momentum built throughout 2025 accelerated in Q4, capping off a strong finish to the year with double-digit sales and earnings growth.
“We delivered above-market, top-line growth across the portfolio, including our core spine franchise, while delivering meaningful margin expansion – reflecting disciplined execution.
“Looking ahead to 2026, our focus lies in driving durable momentum, centered on scaling growth and sustainable operating leverage.
“We are confident in our ability to launch a robust new product pipeline and expand our high-touch sales force, while maintaining speed and agility, as we realize our long-term goal of addressing unmet clinical needs with differentiated procedural solutions.
“We are focused on achieving improved surgical outcomes through the Globus surgical intelligence closed loop ecosystem, bringing together patient selection, surgical techniques and complementary implants.”
Matt Miksic, a bottom 5% analyst from Barclays maintains GMED with a strong buy rating and raises their GMED price target from $118.00 to $123.00, on Feb 25, 2026.
You can dig deeper into what analysts are saying on the Globus Medical stock forecast page.
Metrics for Advanced GMED Traders
Is GMED Growing Revenue?
Last year, GMED earnings were $535.43M. During the past five year, GMED's earnings have grown by 16.5% per year. This was faster than the Medical Devices industry average of 11.95%.
Last year, GMED revenue was $3.14B. In the last 5 year, GMED's revenue has increased by 27.65% per year. This was faster than the Medical Devices industry average of 8.75%.
Dig into GMED's earnings and revenue performance here.
Are GMED executives and large shareholders buying or selling the stock?
Over the last year, executives and large shareholders at GMED have bought more shares than they have sold.
Stephen T. Zarrilli, Director of GMED, was the latest GMED insider to buy. They bought $1,331,750.00 worth of GMED stock on Aug 18, 2026.
Research more about who owns GMED stock here.
Does GMED stock generate passive income?
No, Globus Medical doesn't provide an income stream by paying out dividends.
What do other investors have to say about GMED?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your GMED trade
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your GMED position
Now that you own some GMED stock, you'll want to keep up with your investment.
Create a watchlist to track the most important metrics related to your GMED stock.
GMED Feed
How to Buy Stock in Globus Medical
To reiterate, here are the 6 steps you need to take to buy Globus Medical stock right now:
- Choose where to buy Globus Medical stock
- Sign up for your brokerage account
- Deposit money your investment account
- Research Globus Medical stock
- Make your GMED trade
- Keep an eye on your GMED position
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to monitor your investment in Globus Medical, click below.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.